RYTM- Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 111.9K | $11.19M | - | |
| Other | 25.5K | $2.55M | - | |
| CEO | 14.1K | $1.41M | - | |
| Other | 8.4K | $837.3K | - | |
| Dir | 7.0K | $703.5K | - |
Activity
Buys and sells only
Transactions
10 filings · page 15
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2019 | Foley Todd82 | Director | Sell | 127,544 | $23.11 | $2,947,316.88 | -1.6% | |
| Nov 25, 2019 | Foley Todd82 | Director | Sell | 224,025 | $22.53 | $5,047,557.14 | -2.0% | |
| Nov 21, 2019 | Foley Todd82 | Director | Sell | 206,288 | $21.56 | $4,446,998.43 | -2.3% | |
| May 31, 2019 | Van Der Ploeg Leonardus H.T. | Chief Scientific Officer | Sale+OE | 10,000 | $25.21 | $252,050.00 | -10.6% | |
| May 29, 2019 | Van Der Ploeg Leonardus H.T. | Chief Scientific Officer | Sale+OE | 15,000 | $25.42 | $381,350.00 | -15.0% | |
| Mar 18, 2019 | Gottesdiener Keith Michael | CEO &President | Sell | 10,290 | $30.09 | $309,647.27 | -1.0% | |
| Mar 14, 2019 | Gottesdiener Keith Michael | CEO &President | Sell | 9,288 | $30.06 | $279,182.22 | -0.9% | |
| Feb 27, 2019 | Gottesdiener Keith Michael | CEO And President | Sell | 2,449 | $30.04 | $73,570.69 | -0.2% | |
| Feb 19, 2019 | Gottesdiener Keith Michael | CEO And President | Sell | 12,920 | $30.02 | $387,885.94 | -1.2% | |
| Feb 13, 2019 | Gottesdiener Keith Michael | CEO And President | Sell | 3,934 | $30.00 | $118,020.00 | -0.7% |